Home › Breast Cancer › Wisconsin › Milwaukee
Breast Cancer clinical trials in Milwaukee, WI
23 studies for Breast Cancer are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Zablocki Veterans Administration Medical Center, Milwaukee
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- and 9 more
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecruitingPhase 1
- Research Site, Milwaukee
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RecruitingPhase 3
- Clinical Trial Site, Milwaukee
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RecruitingPhase 3
- Medical College of Wisconsin, Milwaukee
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecruitingPhase 1/2
- Froedtert & MCW Cancer Center, Milwaukee
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecruitingPhase 3
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
RecruitingPhase 2
- Medical College of Wisconsin, Milwaukee
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- and 8 more
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RecruitingPhase 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Recruiting
- Froedtert Hospital, Milwaukee
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
Recruiting
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- UW Cancer Center at ProHealth Care, Waukesha · 17 mi away
- ProHealth D N Greenwald Center, Mukwonago · 25 mi away
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- and 9 more
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Aurora Cancer Care-Milwaukee, Milwaukee
- Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- and 10 more
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
RecruitingObservational study
- Medical College of Wisconsin, Milwaukee
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
RecruitingPhase 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RecruitingObservational study
- Aurora Cancer Care - Wauwatosa, Wauwatosa · 5 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Milwaukee
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
RecruitingPhase 2
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Individuals on Hormone Therapy Breast Cancer Screening Pilot
RecruitingObservational studyHealthy volunteers welcome
- Medical College of Wisconsin, Milwaukee
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RecruitingObservational study
- Columbia St. Mary's, Milwaukee
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Recruiting
- Medical College of Wisconsin, Milwaukee
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Milwaukee
- Cancer (all types)22 studies
- Non-Small Cell Lung Cancer22 studies
- Multiple Myeloma21 studies
- Lung Cancer21 studies
- Prostate Cancer20 studies
- Follicular Lymphoma19 studies
- Non-Hodgkin Lymphoma18 studies
- Pancreatic Cancer18 studies
- Acute Myeloid Leukemia17 studies
- Ovarian Cancer17 studies
- Diffuse Large B-Cell Lymphoma16 studies
- Burkitt Lymphoma16 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.